APRIL ALLEN: Open Payments
NPI 1174268551 · WEBB CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 81 payments from 19 companies in 2025. Trend: 2023 $924 · 2024 $1,396 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $266 |
| Novo Nordisk Inc | 12 | $220 |
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| Lilly USA, LLC | 5 | $84 |
| Verona Pharma, Inc. | 4 | $57 |
| GENZYME CORPORATION | 2 | $48 |
| Astellas Pharma US Inc | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Dexcom, Inc. | 2 | $34 |
Products named: Ozempic, VRAYLAR, BREZTRI, QULIPTA, MOUNJARO, Ohtuvayre, FABRAZYME, Veozah.
Industry payments across MO — which companies pay providers there.
